|
1 Company |
|
1 Product |
|
1 Product |
|
2 Mechanisms of Action |
|
0 Trials |
|
7 News |
|
- ||||||| cilostazol / Generic mfg.
Trial completion: STELLAt: A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina (clinicaltrials.gov) - May 3, 2017
P3, N=100, Completed, Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
Recruiting --> Completed
- ||||||| cilostazol / Generic mfg.
Trial completion: STELLA_Ext: Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina (clinicaltrials.gov) - Jan 30, 2016
P3, N=65, Completed, Sponsor: Korea Otsuka Pharmaceutical Co.,Ltd.
Recruiting --> Completed Recruiting --> Completed
- |||| cilostazol / Generic mfg.
Trial primary completion date: STELLAt: A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina (clinicaltrials.gov) - Oct 20, 2014
P3, N=100, Recruiting, Sponsor: Korea Otsuka Pharmaceutical Co.,Ltd.
Recruiting --> Completed Trial primary completion date: Jan 2015 --> Jul 2015
- |||||||||| cilostazol / Generic mfg.
New P3 trial: STELLA_Ext: Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina (clinicaltrials.gov) - Mar 19, 2014
P3, N=70, Recruiting, Sponsor: Korea Otsuka Pharmaceutical Co.,Ltd.
- |||||||||| cilostazol / Generic mfg.
New P3 trial: STELLAt: A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina (clinicaltrials.gov) - Mar 12, 2014
P3, N=100, Recruiting, Sponsor: Korea Otsuka Pharmaceutical Co.,Ltd.
- | cilostazol / Generic mfg.
Trial completion: STELLAt: Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina (clinicaltrials.gov) - Jul 12, 2012
P2, N=50, Completed, Sponsor: Korea Otsuka Pharmaceutical Co.,Ltd.
Trial primary completion date: Jan 2015 --> Jul 2015 Recruiting --> Completed
- | cilostazol / Generic mfg.
New P2 trial: STELLAt: Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina (clinicaltrials.gov) - Sep 29, 2011
P2, N=50, Completed, Sponsor: Korea Otsuka Pharmaceutical Co.,Ltd.